TAILIEUCHUNG - Báo cáo sinh học: " The effects of DNA formulation and administration route on cancer therapeutic efficacy with xenogenic EGFR DNA vaccine in a lung cancer animal model"

Tuyển tập các báo cáo nghiên cứu về sinh học được đăng trên tạp chí sinh học Journal of Biology đề tài: The effects of DNA formulation and administration route on cancer therapeutic efficacy with xenogenic EGFR DNA vaccine in a lung cancer animal model | Genetic Vaccines and Therapy BioMed Central Open Access The effects of DNA formulation and administration route on cancer therapeutic efficacy with xenogenic EGFR DNA vaccine in a lung cancer animal model Ming-Derg Lai1 2 3 Meng-Chi Yen2 Chiu-Mei Lin4 5 Cheng-Fen Tu1 Chun-Chin Wang6 Pei-Shan Lin6 Huei-Jiun Yang1 and Chi-Chen Lin 6 7 Address Department of Biochemistry and Molecular Biology College of Medicine National Cheng Kung University Taiwan institute of Basic Medicine College of Medicine National Cheng Kung University Taiwan 3Center for Gene Regulation and Signal Transduction Research National Cheng Kung University Tainan Taiwan 4School of Medicine College of Medicine Taipei Medical University Taipei Taiwan 5Department of Emergency Medicine Shin Kong Wu Ho-Su Memorial Hospital Taipei Taiwan institute of Medical Technology College of Life Science National Chung Hsing University Taiwan and 7Department of Medical Research and Education Taichung-Veterans General Hospital Taichung Taiwan Email Ming-Derg Lai - a1211207@ Meng-Chi Yen - iqri@ Chiu-Mei Lin - james@ Cheng-Fen Tu - dnavaccine@ Chun-Chin Wang - tony10600@ Pei-Shan Lin - butterfly7557@ Huei-JiunYang-snowangel0209@ Chi-Chen Lin - lincc@ Corresponding author Published 30 January 2009 Received 29 October 2008 Accepted 30 January 2009 Genetic Vaccines and Therapy 2009 7 2 doi 186 1479-0556-7-2 This article is available from http content 7 1 2 2009 Lai et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Tyrosine kinase inhibitor gefitinib is effective against lung cancer cells carrying mutant epidermal growth factor

Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.